Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Abstract
The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an imminent need to better understand this new virus and to develop ways to control its spread. In this study, we sought to gain ins …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
covid-19
sars-cov-2
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
genome
Viral
Phylogeny
pneumonia
epitopes
t-lymphocyte / immunology
protein structure
tertiary
sars virus / genetics
viral vaccines / immunology*
betacoronavirus / immunology*
spike glycoprotein
viral / prevention & control
phosphoproteins
pmid:32106567
pmc7150947
doi:10.3390/v12030254
syed faraz ahmed
ahmed a quadeer
matthew r mckay
betacoronavirus / genetics
covid-19 vaccines
coronavirus infections / prevention & control
coronavirus nucleocapsid proteins
epitope mapping
b-lymphocyte / genetics
b-lymphocyte / immunology
t-lymphocyte / genetics
nucleocapsid proteins / genetics
nucleocapsid proteins / immunology*
sars virus / immunology
coronavirus / genetics
coronavirus / immunology*
Citation
ID:
271840
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
271840
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
